Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_assertion type Assertion NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_head.
- NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_assertion description "[Immunohistochemical analysis on a tissue microarray consisting of 91 human prostate specimens, including normal, prostatic hyperplasia, high-grade prostatic intraepithelial neoplasia, and invasive carcinoma, revealed that overexpression of LMO2 was significantly associated with advanced tumour stage, as measured by Gleason score (p = 0.012), as well as with the development of distant metastasis (p = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_provenance.
- NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_assertion evidence source_evidence_literature NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_provenance.
- NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_assertion SIO_000772 17167821 NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_provenance.
- NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_assertion wasDerivedFrom befree-2016 NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_provenance.
- NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_assertion wasGeneratedBy ECO_0000203 NP584246.RAKbmE-_24XFAT-T60LJTiT6oryFRfcutB5PtdVL356Gg130_provenance.